Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 4, Pages e1111505
Publisher
Informa UK Limited
Online
2015-12-21
DOI
10.1080/2162402x.2015.1111505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FIGO 2013 staging system for ovarian cancer
- (2015) Shivani R. Kandukuri et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Plasma immune analytes in patients with epithelial ovarian cancer
- (2015) Matthew S. Block et al. CYTOKINE
- Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
- (2014) H Nishio et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Role of IL-17F T7488C polymorphism in carcinogenesis: a meta-analysis
- (2014) Fen Yao et al. TUMOR BIOLOGY
- Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
- (2014) P Zhang et al. Cell Death & Disease
- Chronic Inflammation and Cytokines in the Tumor Microenvironment
- (2014) Glauben Landskron et al. Journal of Immunology Research
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer
- (2013) Chunyan Lan et al. CELL AND TISSUE RESEARCH
- Tu-be or not tu-be: That is the question… About serous ovarian carcinogenesis
- (2013) G. Chene et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
- (2013) Tina Verschuere et al. JOURNAL OF NEURO-ONCOLOGY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer
- (2013) Faruk Tas et al. TUMOR BIOLOGY
- A role for CCL2 in both tumor progression and immunosurveillance
- (2013) Ming Li et al. OncoImmunology
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2
- (2012) L.-Y. Chung et al. CLINICAL CANCER RESEARCH
- High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion
- (2012) Ha-Jeong Kim et al. EUROPEAN JOURNAL OF CANCER
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
- (2012) Lei Yu et al. GYNECOLOGIC ONCOLOGY
- Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
- (2012) Brian F. Zamarron et al. International Journal of Biological Sciences
- Alternative activation of tumor-associated macrophages by IL-4
- (2011) Hao-Wei Wang et al. CELL CYCLE
- IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer
- (2011) Toshio Fujisawa et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin
- (2011) Komiyama ONCOLOGY REPORTS
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
- (2010) Sven Mahner et al. BMC CANCER
- Myeloid-Derived Suppressor Cells in Human Cancer
- (2010) Srinivas Nagaraj et al. CANCER JOURNAL
- Ovarian cancer creates a suppressive microenvironment to escape immune elimination
- (2010) Refika Yigit et al. GYNECOLOGIC ONCOLOGY
- Chemotherapy Induces Macrophage Chemoattractant Protein-1 Production in Ovarian Cancer
- (2010) Melissa A. Geller et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- p53 autoantibodies, cytokine levels and ovarian carcinogenesis
- (2009) Miyun Tsai-Turton et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression
- (2009) Chiara Napoletano et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Evidence of galectin-1 involvement in glioma chemoresistance☆
- (2008) Marie Le Mercier et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started